Open Longevity is a project that initiates, organizes and guarantees the openness of clinical trials of anti-aging therapies.
Two important components of our project are online expert system, that interprets user's biomedical information in terms of aging biology, and new infrastructure for anti-aging clinical trials. They are closely connected: the obtained data of trials is taken into account of the expert system operation, and the funds raised from users are spent on anti-aging research.
At the first stage, having the platform development and launching the first trials as our aim, we raise funds through the ICO. Our task is to build a self-sufficient system that provides paid services to individuals but at the same time solves important tasks for humanity on a noncommercial basis.
We do not plan to protect therapies that we are about to test with patents—the research results the will be made publicly available. We are leading patients' energy toward fight against aging, and from our experience, it is the policy of openness that attracts projects, funding, scientists and volunteers to us.
One of the common concerns in the industry is that, once appeared on the market, the medicine for old age will become the exclusive prerogative of the elite. The openness of our project is a possible solution to this problem.
Moreover, publication of both final and intermediate results, as well as research protocols and all related materials, will give us the highest level of expertise.
All clinical trials will be carried out strictly in accordance with the existing norms. We will prepare brochures describing the design of the experiment, questionnaires, informed consent forms, permissions of ethical committees. We will involve laboratories, clinical institutions and CRO (Contract Research Organization), which traditionally carry out similar research.
We will include patients into a global movement of searching and testing potential aging therapies that, once proven effective, will immediately become part of their own lives.